| |
 |
|
Class Information
Number: 514/426
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) > The five-membered hetero ring consists of one nitrogen and four carbons > Nitrogen bonded directly to the five-membered hetero ring by nonionic bonding
Description: Subject matter wherein nitrogen is bonded directly to the five-membered hetero ring by nonionic bonding.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7557137 |
Gamma-lactams as beta-secretase inhibitors |
Jul. 7, 2009 |
| 7541379 |
Di(amido-substituted)heteroarene compounds as osteoblastogenesis agents |
Jun. 2, 2009 |
| 7538124 |
Biphenylcarboxamides useful as lipid lowering agents |
May. 26, 2009 |
| 7507760 |
N-type calcium channel blockers |
Mar. 24, 2009 |
| 7504422 |
Polyamine compounds |
Mar. 17, 2009 |
| 7485665 |
Medicinal composition |
Feb. 3, 2009 |
| 7485641 |
Substituted 3-amino-pyrrolidino-4-lactams |
Feb. 3, 2009 |
| 7485320 |
Liposome for incorporating large amounts of hydrophobic substances |
Feb. 3, 2009 |
| 7446115 |
Peptidomimetic ligands for cellular receptors and ion channels |
Nov. 4, 2008 |
| 7446125 |
Derivatives of nitroproline compounds, processes of manufacture and uses in the treatment of integrin mediated disorders |
Nov. 4, 2008 |
| 7399776 |
Polyamine compounds for treating chemokine receptor mediated diseases |
Jul. 15, 2008 |
| 7390830 |
Remedies or prophylactics for diseases in association with chemokines |
Jun. 24, 2008 |
| 7381741 |
3-amino-2-phenylpyrrolidine derivatives |
Jun. 3, 2008 |
| 7329685 |
1-Phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor Xa inhibitors for the treatment of acute vascular diseases |
Feb. 12, 2008 |
| 7326729 |
CXCR1 and CXCR2 chemokine antagonists |
Feb. 5, 2008 |
| 7267826 |
Plant protection agents |
Sep. 11, 2007 |
| 7256191 |
Materials and methods for the treatment of depression |
Aug. 14, 2007 |
| 7250443 |
Pyrrole based inhibitors of glycogen synthase kinase 3 |
Jul. 31, 2007 |
| 7223788 |
Substituted N-aryl heterocycles, process for their preparation and their use as medicaments |
May. 29, 2007 |
| 7214701 |
Active substance combinations having insecticidal and acaricdal properties |
May. 8, 2007 |
| 7198803 |
Sustained release oral preparations |
Apr. 3, 2007 |
| 7183298 |
Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors |
Feb. 27, 2007 |
| 7078414 |
Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions comprising them |
Jul. 18, 2006 |
| 7045521 |
Cyclic derivatives as modulators of chemokine receptor activity |
May. 16, 2006 |
| 7005439 |
Compounds |
Feb. 28, 2006 |
| 6992081 |
Compounds to treat Alzheimer's disease |
Jan. 31, 2006 |
| 6982263 |
Nitriles useful as reversible inhibitors of cysteine proteases |
Jan. 3, 2006 |
| 6974825 |
Compounds with analgesic effect |
Dec. 13, 2005 |
| 6949553 |
Aliphatic compounds, their synthesis method, and utilization of the same |
Sep. 27, 2005 |
| 6939891 |
Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists |
Sep. 6, 2005 |
| 6916814 |
Methods of treating cytokine mediated diseases |
Jul. 12, 2005 |
| 6911458 |
Compounds |
Jun. 28, 2005 |
| 6878733 |
Formulations for pharmaceutical agents ionizable as free acids or free bases |
Apr. 12, 2005 |
| 6867221 |
Cyclic amine compounds and pharmaceutical composition containing the same |
Mar. 15, 2005 |
| 6864276 |
Active substance combinations having insecticidal and acaricidal properties |
Mar. 8, 2005 |
| 6858623 |
Compounds useful as reversible inhibitors of cysteine proteases |
Feb. 22, 2005 |
| 6835727 |
Cathepsin cysteine protease inhibitors |
Dec. 28, 2004 |
| 6747029 |
Dopamine D4 receptor antagonists as treatment for attention deficit-hyperactivity disorder |
Jun. 8, 2004 |
| 6743787 |
N-(4-sulfonylaryl)cyclylamine-2-hydroxyethylamines as beta-3 adrenergic receptor agonists |
Jun. 1, 2004 |
| 6716854 |
Treatments for restless legs syndrome |
Apr. 6, 2004 |
| 6706712 |
Cyclic derivatives as modulators of chemokine receptor activity |
Mar. 16, 2004 |
| 6680317 |
IL-8 receptor antagonists |
Jan. 20, 2004 |
| 6677353 |
Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
Jan. 13, 2004 |
| 6677341 |
(R)-Chiral halogenated substituted heteroaryl benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
Jan. 13, 2004 |
| 6667319 |
Neuropeptide Y Y5 receptor antagonists |
Dec. 23, 2003 |
| 6660732 |
Compounds useful as anti-inflammatory agents |
Dec. 9, 2003 |
| 6656933 |
Compounds useful as anti-inflammatory agents |
Dec. 2, 2003 |
| 6653336 |
Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders |
Nov. 25, 2003 |
| 6649642 |
Succinate derivative compounds useful as cysteine protease inhibitors |
Nov. 18, 2003 |
| 6649603 |
Cyclylamine sulfonamides as .beta.3-adrenergic receptor agonists |
Nov. 18, 2003 |
|
|
|
